Outcomes in patients with invasive candidiasis treated with anidulafungin or fluconazole: Comparison of response to treatment in ICU patients and/or patients with end-organ dysfunction

被引：0
|
作者：
Shorr, Andrew F. [1 ]
Kett, Dan H. [2 ]
Sanchez, Sonia [3 ]
Gasper, Sabina [3 ]
Schlamm, Haran T. [3 ]
机构：
[1] Washington Hosp Ctr, Washington, DC 20010 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Pfizer Inc, New York, NY USA
来源：
CRITICAL CARE MEDICINE | 2007年 / 35卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
899
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 50 条
  • [21] Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
    Boonstra, J. M.
    Martson, A. G.
    Sandaradura, I
    Kosterink, J. G. W.
    van der Werf, T. S.
    Marriott, D. J. E.
    Zijlstra, J. G.
    Touw, D. J.
    Alffenaar, J. W. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)
  • [22] Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
    Patrick J. van der Geest
    Nicole G. M. Hunfeld
    Sophie E. Ladage
    A. B. Johan Groeneveld
    BMC Infectious Diseases, 16
  • [23] Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
    van der Geest, Patrick J.
    Hunfeld, Nicole G. M.
    Ladage, Sophie E.
    Groeneveld, A. B. Johan
    BMC INFECTIOUS DISEASES, 2016, 16
  • [24] Postmortem Evaluation of Kidney and Other End-Organ Toxicity in Glioblastoma Patients Treated with Bevacizumab
    Tian, X.
    Zhu, J. J.
    Linendoll, N.
    Pfannl, R.
    Pilichowska, M.
    MODERN PATHOLOGY, 2012, 25 : 6A - 7A
  • [25] Postmortem Evaluation of Kidney and Other End-Organ Toxicity in Glioblastoma Patients Treated with Bevacizumab
    Tian, X.
    Zhu, J. J.
    Linendoll, N.
    Pfannl, R.
    Pilichowska, M.
    LABORATORY INVESTIGATION, 2012, 92 : 6A - 7A
  • [26] POSTMORTEM EVALUATION OF END-ORGAN TOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED WITH TEMOZOLOMIDE, BEVACIZUMAB AND IRINOTECAN
    Lu, G.
    Rao, M.
    Zhu, P.
    Tian, X.
    Linendoll, N.
    Pilichowska, M.
    Glass, W. F.
    Hunter, R.
    Zhu, J.
    NEURO-ONCOLOGY, 2017, 19 : 84 - 84
  • [27] Is epistaxis evidence of end-organ damage in patients with hypertension?
    Neto, JFL
    Fuchs, FD
    Facco, SR
    Gus, M
    Fasolo, L
    Mafessoni, R
    Gleissner, AL
    LARYNGOSCOPE, 1999, 109 (07): : 1111 - 1115
  • [28] Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
    Vuichard, Danielle
    Weisser, Maja
    Orasch, Christina
    Frei, Reno
    Heim, Dominik
    Passweg, Jakob R.
    Widmer, Andreas F.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [29] Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
    Danielle Vuichard
    Maja Weisser
    Christina Orasch
    Reno Frei
    Dominik Heim
    Jakob R Passweg
    Andreas F Widmer
    BMC Infectious Diseases, 14
  • [30] CHARACTERISTICS OF CAROTID BAROREFLEX DYSFUNCTION IN PATIENTS WITH DIABETES-MELLITUS - RELATION TO END-ORGAN RESPONSIVENESS
    PRYSTOWSKY, EN
    SHETA, M
    ADAMS, D
    VINICOR, F
    CLINICAL RESEARCH, 1985, 33 (04): : A869 - A869
12345